Welby

Welby Net Margin

The Net Profit Margin of Welby (4438.T) as of Oct 19, 2026 is -84.89 %. In the previous year, Net Profit Margin was -152.37 % — a change of -44.29% (higher).

Net Margin

-84.89 %

YoY

-44.29%

Last updated:

Net Profit Margin of Welby is 2025 -84.89 % . Net Profit Margin of Welby was 2024 -152.37 % . It decreases by -44.29% higher compared to the previous year.

For Welby, the net margin of -85.3% is down versus -11.5% a few years ago.

The Welby Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2018
21.85 JPY
Jan 1, 2019
-1.42 JPY
Jan 1, 2020
-40.84 JPY
Jan 1, 2021
-11.47 JPY
Jan 1, 2022
3.23 JPY
Jan 1, 2023
-87.83 JPY
Jan 1, 2024
-152.37 JPY
Jan 1, 2025
-84.89 JPY
The Welby Net Margin history
YEARNet MarginYoY
-84.89 %-44.29%
-152.37 %+73.50%
-87.83 %-2,822.13%
3.23 %-128.13%
-11.47 %-71.91%
-40.84 %+2,785.23%
-1.42 %-106.48%
21.85 %-234.80%
-16.21 %-69.88%
-53.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Welby Stock analysis

What does Welby do? Welby Inc is a Japanese company operating in the Health Care sector, headquartered in Chuo-Ku, Tokyo. The company has 40 employees and went public on March 29, 2019, with the ticker 4438.T and ISIN JP3155410008. Welby Inc develops patient health record platform services, focusing on creating a personal health record (PHR) platform within the medical field. The company provides two main services: a disease solution service, which involves developing PHR platforms for pharmaceutical companies upon request, and Welby My Carte, a cloud-based service designed to support patients in managing their daily health habits, particularly for conditions such as diabetes and hypertension. The company's website is https://welby.jp/. Welby Inc operates with a focus on digital health solutions, aiming to enhance patient self-management and provide tailored health record systems for medical and pharmaceutical partners. The company's business model centers on delivering technology-driven health management tools that support both healthcare providers and patients. As a publicly traded company, Welby Inc is listed on the Tokyo Stock Exchange. The company's operations are based in Chuo-Ku, Tokyo, and it serves a market that includes healthcare institutions and pharmaceutical firms seeking digital health solutions. The firm's services are designed to improve patient engagement and health outcomes through accessible, technology-based platforms. Welby is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Welby stock

Net Profit Margin of Welby is -84.89 % in 2025.

Net Profit Margin of Welby changed from -152.37 % to -84.89 %, representing a -44.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Welby since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Welby with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Welby

All Key Metrics — Welby